AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities - Fierce Biotech

2026-01-29 - 11:10

AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities Fierce Biotech